- Home
- TARS vs CSGS Comparison
TARS vs CSGS Comparison
Compare TARS & CSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- CSGS
- Stock Information
- Founded
- TARS 2016
- CSGS 1994
- Country
- TARS United States
- CSGS United States
- Employees
- TARS N/A
- CSGS 5800
- Industry
- TARS Medicinal Chemicals and Botanical Products
- CSGS EDP Services
- Sector
- TARS Health Care
- CSGS Technology
- Exchange
- TARS Nasdaq
- CSGS Nasdaq
- Market Cap
- TARS 1.7B
- CSGS 1.9B
- IPO Year
- TARS 2020
- CSGS 1996
- Fundamental
- Price
- TARS $41.13
- CSGS $64.08
- Analyst Decision
- TARS Strong Buy
- CSGS Buy
- Analyst Count
- TARS 7
- CSGS 8
- Target Price
- TARS $67.14
- CSGS $68.29
- AVG Volume (30 Days)
- TARS 594.1K
- CSGS 201.1K
- Earning Date
- TARS 08-07-2025
- CSGS 08-06-2025
- Dividend Yield
- TARS N/A
- CSGS 1.97%
- EPS Growth
- TARS N/A
- CSGS 33.32
- EPS
- TARS N/A
- CSGS 2.92
- Revenue
- TARS $233,674,000.00
- CSGS $1,201,566,000.00
- Revenue This Year
- TARS $122.94
- CSGS $4.49
- Revenue Next Year
- TARS $44.14
- CSGS $3.92
- P/E Ratio
- TARS N/A
- CSGS $22.21
- Revenue Growth
- TARS 449.03
- CSGS 3.08
- 52 Week Low
- TARS $20.08
- CSGS $39.86
- 52 Week High
- TARS $57.28
- CSGS $67.60
- Technical
- Relative Strength Index (RSI)
- TARS 43.15
- CSGS 50.09
- Support Level
- TARS $38.52
- CSGS $64.17
- Resistance Level
- TARS $41.48
- CSGS $66.99
- Average True Range (ATR)
- TARS 1.51
- CSGS 1.38
- MACD
- TARS 0.12
- CSGS 0.01
- Stochastic Oscillator
- TARS 48.21
- CSGS 53.33
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About CSGS CSG Systems International Inc.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.